AKR1B10 Antibodies

Santa Cruz Biotechnology provides a broad selection of AKR1B10 monoclonal antibodies for a variety of research applications. AKR1B10 monoclonal antibodies excel in techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKR1B10, or Aldose Reductase, plays a crucial role in the metabolism of carbohydrates and is involved in the reduction of aldehydes to their corresponding alcohols. AKR1B10 functions in various physiological processes, including the regulation of glucose levels and the protection of cells from oxidative stress. AKR1B10 dysregulation has been implicated in several diseases, making it an important target for therapeutic research. Researchers worldwide utilize AKR1B10 monoclonal antibodies to advance their understanding of cellular processes and disease mechanisms. The exceptional specificity of AKR1B10 monoclonal antibodies enables precise detection and analysis in diverse experimental settings. Santa Cruz Biotechnology monoclonal antibodies continue to support breakthrough discoveries in biomedical research, advancing scientific knowledge and potential therapeutic developments.